Cargando…
Adiponectin in Osteoarthritis: Pathophysiology, Relationship with Obesity and Presumptive Diagnostic Biomarker Potential
Osteoarthritis (OA) is a multifactorial, irreversible age- and obesity-induced joint degenerative disease, with an increasing incidence in developed countries. With a pathophysiology and etiology that are currently under-investigated, the only available disease-modifying treatment relies solely on t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871474/ https://www.ncbi.nlm.nih.gov/pubmed/35204546 http://dx.doi.org/10.3390/diagnostics12020455 |
_version_ | 1784657004245024768 |
---|---|
author | Ilia, Iosif Nitusca, Diana Marian, Catalin |
author_facet | Ilia, Iosif Nitusca, Diana Marian, Catalin |
author_sort | Ilia, Iosif |
collection | PubMed |
description | Osteoarthritis (OA) is a multifactorial, irreversible age- and obesity-induced joint degenerative disease, with an increasing incidence in developed countries. With a pathophysiology and etiology that are currently under-investigated, the only available disease-modifying treatment relies solely on total joint arthroplasty, which entails major economic burdens. Recently, the research focus has shifted towards the evaluation of metabolically active mediators secreted by the adipose tissue, which could be potential targets for a better understanding of the mechanisms involved in OA onset and development. Of note, adiponectin has drawn a great deal of attention, since it is the most abundant type of circulating adipokine and has been highly associated with OA occurrence. Thus far, studies have been controversial in establishing whether adiponectin possesses a destructive or protective role in OA development. Therefore, we critically and systematically reviewed, herein, the roles of adiponectin in the pathophysiology of OA, the link between obesity, adiponectin expression and the progression of OA, as well as its potential role as a future biomarker for a more optimized and reliable diagnosis of this degenerative disorder. |
format | Online Article Text |
id | pubmed-8871474 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88714742022-02-25 Adiponectin in Osteoarthritis: Pathophysiology, Relationship with Obesity and Presumptive Diagnostic Biomarker Potential Ilia, Iosif Nitusca, Diana Marian, Catalin Diagnostics (Basel) Review Osteoarthritis (OA) is a multifactorial, irreversible age- and obesity-induced joint degenerative disease, with an increasing incidence in developed countries. With a pathophysiology and etiology that are currently under-investigated, the only available disease-modifying treatment relies solely on total joint arthroplasty, which entails major economic burdens. Recently, the research focus has shifted towards the evaluation of metabolically active mediators secreted by the adipose tissue, which could be potential targets for a better understanding of the mechanisms involved in OA onset and development. Of note, adiponectin has drawn a great deal of attention, since it is the most abundant type of circulating adipokine and has been highly associated with OA occurrence. Thus far, studies have been controversial in establishing whether adiponectin possesses a destructive or protective role in OA development. Therefore, we critically and systematically reviewed, herein, the roles of adiponectin in the pathophysiology of OA, the link between obesity, adiponectin expression and the progression of OA, as well as its potential role as a future biomarker for a more optimized and reliable diagnosis of this degenerative disorder. MDPI 2022-02-10 /pmc/articles/PMC8871474/ /pubmed/35204546 http://dx.doi.org/10.3390/diagnostics12020455 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ilia, Iosif Nitusca, Diana Marian, Catalin Adiponectin in Osteoarthritis: Pathophysiology, Relationship with Obesity and Presumptive Diagnostic Biomarker Potential |
title | Adiponectin in Osteoarthritis: Pathophysiology, Relationship with Obesity and Presumptive Diagnostic Biomarker Potential |
title_full | Adiponectin in Osteoarthritis: Pathophysiology, Relationship with Obesity and Presumptive Diagnostic Biomarker Potential |
title_fullStr | Adiponectin in Osteoarthritis: Pathophysiology, Relationship with Obesity and Presumptive Diagnostic Biomarker Potential |
title_full_unstemmed | Adiponectin in Osteoarthritis: Pathophysiology, Relationship with Obesity and Presumptive Diagnostic Biomarker Potential |
title_short | Adiponectin in Osteoarthritis: Pathophysiology, Relationship with Obesity and Presumptive Diagnostic Biomarker Potential |
title_sort | adiponectin in osteoarthritis: pathophysiology, relationship with obesity and presumptive diagnostic biomarker potential |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871474/ https://www.ncbi.nlm.nih.gov/pubmed/35204546 http://dx.doi.org/10.3390/diagnostics12020455 |
work_keys_str_mv | AT iliaiosif adiponectininosteoarthritispathophysiologyrelationshipwithobesityandpresumptivediagnosticbiomarkerpotential AT nituscadiana adiponectininosteoarthritispathophysiologyrelationshipwithobesityandpresumptivediagnosticbiomarkerpotential AT mariancatalin adiponectininosteoarthritispathophysiologyrelationshipwithobesityandpresumptivediagnosticbiomarkerpotential |